These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2783330)
21. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery. Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462 [TBL] [Abstract][Full Text] [Related]
22. Transmyocardial fibrinolytic activity in patients with unstable angina pectoris. Daniel WC; Meidell RS; Hillis LD; Lange RA Coron Artery Dis; 1996 Jan; 7(1):45-9. PubMed ID: 8773432 [TBL] [Abstract][Full Text] [Related]
23. Sex differences in the determinants of fibrinolytic activity. MacCallum PK; Cooper JA; Howarth DJ; Meade TW; Miller GJ Thromb Haemost; 1998 Mar; 79(3):587-90. PubMed ID: 9531046 [TBL] [Abstract][Full Text] [Related]
24. Levels of fibrinolytic activators and inhibitors in plasma after severe trauma. Sørensen JV Blood Coagul Fibrinolysis; 1994 Feb; 5(1):43-9. PubMed ID: 7514044 [TBL] [Abstract][Full Text] [Related]
25. [Problems in measuring parameters of the fibrinolytic system: circadian rhythm of tissue-type plasminogen activator and plasminogen activator inhibitor]. Köhler M; Miyashita C Klin Wochenschr; 1988; 66 Suppl 12():62-7. PubMed ID: 3126347 [TBL] [Abstract][Full Text] [Related]
26. Plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary artery disease. Grancha S; Estellés A; Tormo G; Falco C; Gilabert J; España F; Cano A; Segui R; Aznar J Thromb Haemost; 1999 Apr; 81(4):516-21. PubMed ID: 10235431 [TBL] [Abstract][Full Text] [Related]
27. Plasminogen activator system in smokers and non-smokers with and without periodontal disease. Buduneli N; Buduneli E; Kardeşler L; Lappin D; Kinane DF J Clin Periodontol; 2005 Apr; 32(4):417-24. PubMed ID: 15811061 [TBL] [Abstract][Full Text] [Related]
28. Impaired fibrinolysis in obstructive jaundice--evidence from clinical and experimental studies. Colucci M; Altomare DF; Chetta G; Triggiani R; Cavallo LG; Semeraro N Thromb Haemost; 1988 Aug; 60(1):25-9. PubMed ID: 3142090 [TBL] [Abstract][Full Text] [Related]
29. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Erem C Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444 [TBL] [Abstract][Full Text] [Related]
30. Mild hyperhomocysteinemia is associated with a decreased fibrinolytic activity in patients after ST-elevation myocardial infarction. Speidl WS; Nikfardjam M; Niessner A; Zeiner A; Jordanova N; Zorn G; Maurer G; Schreiber W; Wojta J; Huber K Thromb Res; 2007; 119(3):331-6. PubMed ID: 16616324 [TBL] [Abstract][Full Text] [Related]
31. [Quantification of a specific inhibitor (PAI-1) of tissue-type plasminogen activator (t-PA) in the plasma]. Masson C; Angles-Cano E Ann Biol Clin (Paris); 1989; 47(5):269-74. PubMed ID: 2500878 [TBL] [Abstract][Full Text] [Related]
32. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes. Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392 [TBL] [Abstract][Full Text] [Related]
33. Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients--relationship with plasma insulin. Juhan-Vague I; Roul C; Alessi MC; Ardissone JP; Heim M; Vague P Thromb Haemost; 1989 Jun; 61(3):370-3. PubMed ID: 2678583 [TBL] [Abstract][Full Text] [Related]
34. Diurnal variation of the fibrinolytic system. Grimaudo V; Hauert J; Bachmann F; Kruithof EK Thromb Haemost; 1988 Jun; 59(3):495-9. PubMed ID: 3142085 [TBL] [Abstract][Full Text] [Related]
35. Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasma. Jørgensen M; Philips M; Thorsen S; Selmer J; Zeuthen J Thromb Haemost; 1987 Oct; 58(3):872-8. PubMed ID: 3124286 [TBL] [Abstract][Full Text] [Related]
36. Potential roles of plasminogen activator system in coronary vascular remodeling induced by long-term nitric oxide synthase inhibition. Kaikita K; Schoenhard JA; Painter CA; Ripley RT; Brown NJ; Fogo AB; Vaughan DE J Mol Cell Cardiol; 2002 Jun; 34(6):617-27. PubMed ID: 12054849 [TBL] [Abstract][Full Text] [Related]
37. Plasminogen activators and plasminogen activator inhibitors in gingival crevicular fluid of cyclosporin A-treated patients. Buduneli N; Buduneli E; Ciotanar S; Atilla G; Lappin D; Kinane D J Clin Periodontol; 2004 Jul; 31(7):556-61. PubMed ID: 15191592 [TBL] [Abstract][Full Text] [Related]
38. Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man. Brommer EJ; Derkx FH; Schalekamp MA; Dooijewaard G; vd Klaauw MM Thromb Haemost; 1988 Jun; 59(3):404-11. PubMed ID: 3142078 [TBL] [Abstract][Full Text] [Related]
39. Plasminogen activator and plasminogen activator inhibitor activities in a reference population. Krishnamurti C; Tang DB; Barr CF; Alving BM Am J Clin Pathol; 1988 Jun; 89(6):747-52. PubMed ID: 3259399 [TBL] [Abstract][Full Text] [Related]
40. [A study on the circadian variation of tissue-type plasminogen activator and its rapid inhibitor in patients with coronary heart disease]. Chen ZY Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Jun; 21(3):163-4, 188. PubMed ID: 8243232 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]